Momelotinib

Momelotinib, also known as Ojjaara, is a medication specifically for people with myelofibrosis, especially those who also have anemia (low red blood cell levels). This treatment works to help shrink an enlarged spleen and relieve other common symptoms of myelofibrosis. A key action of Momelotinib is helping your body produce more red blood cells, which may reduce the need for blood transfusions. This topic provides information about how Momelotinib addresses these important aspects of myelofibrosis care.